SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-030374
Filing Date
2022-11-03
Accepted
2022-11-03 17:20:56
Documents
18
Period of Report
2022-11-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48895
2 ex4-1.htm EX-4.1 109106
3 ex4-2.htm EX-4.2 92245
4 ex4-3.htm EX-4.3 177966
5 ex10-1.htm EX-10.1 233599
6 ex99-1.htm EX-99.1 14828
7 ex99-1_001.jpg GRAPHIC 5314
  Complete submission text file 0001493152-22-030374.txt   987289

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20221103.xsd EX-101.SCH 3257
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20221103_lab.xml EX-101.LAB 34240
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20221103_pre.xml EX-101.PRE 22379
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3609
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 221359179
SIC: 2834 Pharmaceutical Preparations